Patents by Inventor Xiangzhen Sun

Xiangzhen Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240174760
    Abstract: Disclosed in the present invention is a nanobody, comprising a heavy chain variable region containing CDR1, CDR2 and/or CDR3, and having the function of recognizing and binding to BCMA. Reference can be made to the text for specific CDR sequences. Also disclosed in the present invention are a BCMA binding molecule, a composition comprising the nanobody or BCMA binding molecule, a BCMA detection agent, and an application of the nanobody, the BCMA binding molecule, or the composition in preparation of a drug for treating a BCMA related disease. The nanobody, BCMA binding molecule, and composition in the present invention can recognize and bind to BCMA, and have potential utility for treatment of BCMA related diseases.
    Type: Application
    Filed: March 22, 2022
    Publication date: May 30, 2024
    Inventors: Bo PENG, Jiaguo LI, Haixiang YU, Xiangzhen LIU, Yan SUN, Weimin ZHU, Qijun QIAN
  • Publication number: 20240132526
    Abstract: The present application provides a preparation method for trimethyl aluminum, comprising the steps of: reacting methyl aluminum dichloride or sesquimethyl aluminium chloride or dimethyl aluminum chloride with a system of metal M and methyl chloride in the presence of catalyst and solvent to produce trimethyl aluminum and chloride of metal M; wherein the catalyst is selected from metals or their ions which rank after metallic aluminum in the electrochemical series; the metal M is selected from alkali metals, alkaline earth metals or combinations thereof. The catalyst can significantly increase the reaction rate, thus allowing the reaction to be operated under very simple experimental conditions such as near atmospheric pressure, with higher reaction yields and higher purity of the products, and without by-products of aluminum metal and unreacted alkali or alkaline earth metals in products, making the handling of the products easier.
    Type: Application
    Filed: April 1, 2021
    Publication date: April 25, 2024
    Inventors: Min Yang, Xue Yang, Xiangzhen Sun
  • Publication number: 20130137889
    Abstract: Strecker reagents, their derivatives and methods for forming the same and improved Strecker reaction are provided. The electrophiles for asymmetric Strecker reaction include achiral N-phosphorazides, N-phosphoramides, N-phosphonyl imines and their derivatives. The nucleophiles for asymmetric Strecker reaction include chiral BINOL-derived azides, amides, imines and their derivatives, the chiral and achiral diol-based cyanides and their derivatives, the chiral and achiral diamine-based cyanides and their derivatives, the chiral and achiral amino alcohol-based cyanides and their derivatives, the Strecker nucleophiles that are derived from chiral and achiral hydroxyl carboxylic acids and amino acids. Methods of forming the electrophile for asymmetric Strecker reaction comprise the reactions with steps of: a) synthesizing phosphoryl chloride from achiral diamine; b) synthesizing phosphorous azide; c) synthesizing phosphoramide; d) synthesizing the corresponding achiral N-phosphonyl imines.
    Type: Application
    Filed: March 26, 2010
    Publication date: May 30, 2013
    Applicants: NANJING UNIVERSITY, TEXAS TECH UNIVERSITY, NOWA PHARMACEUTICALS CO., LTD.
    Inventors: Guigen Li, Xiangzhen Sun, Huabing Chen
  • Publication number: 20100160681
    Abstract: This application relates to the design and synthesis of new chiral imines reagents which can be utilized for the synthesis of chiral drugs and their precursors. It describes the design of the free NH2-group-attached chiral phosphoramides, a chiral N-phosphonimines and the methods for forming the same. The free NH2-group-attached chiral phosphoramides, having the structure of formula (I): wherein R1 and R2 are independently any organic groups. The synthesis of N-phosphoramides was performed starting from chiral 1,2-diamines via the following steps: N,N?-dialkylation consisting of aldehyde condensation and reduction, cyclization with phosphoryl halide, substitution of halide with azide anion and hydrogenation of azides. The N-phosphonyl imines are synthesized by condensation of N-phosphoramides with aldehydes. Quantitative yield was obtained for each of the four steps without special purification. All precursors were obtained as white solids.
    Type: Application
    Filed: December 16, 2009
    Publication date: June 24, 2010
    Applicant: NOWA Pharmaceuticals, Co., Ltd.
    Inventors: Xiangzhen Sun, Li Guigen